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Brain collateral circulation is an essential compensatory mechanism in response to acute brain 
ischemia. To study the temporal evolution of brain macro and microcollateral recruitment 
and their reciprocal interactions in response to different ischemic conditions, we applied a 
combination of complementary techniques (T2 weighted magnetic resonance imaging [MRI], 
time of flight [TOF] angiography [MRA], cerebral blood flow [CBF] imaging and histology) in 
two different mouse models. Hypoperfusion was either induced by permanent bilateral 
common carotid artery stenosis (BCCAS) or 60 minute transient unilateral middle cerebral 
artery occlusion (MCAO). 
In both models, collateralization is a very dynamic phenomenon with a global effect affecting 
both hemispheres. Patency of ipsilateral posterior communicating artery (PcomA) represents 
the main variable survival mechanism and the main determinant of stroke lesion volume and 
recovery in MCAO whereas the  promptness of external carotid artery retrograde flow 
recruitment together with PcomA patency, critically influence survival, brain ischemic lesion 
volume and retinopathy in BCCAS mice. Finally, different ischemic gradients shape 
microcollateral density and size. 
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INTRODUCTION 
Collateral circulation represents an essential neuroprotective mechanism during severe acute 
brain ischemia-hypoxia.  Despite the critical importance of collateral arteries, their clinical and 
neuroradiological assessment in patients remains a major challenge 1,2. First, collateral 
arteries represent a complex trait, highly influenced by genetic, sex and age-related 
variability. Second, they are recruited exclusively under moderate-severe acute ischemic 
conditions like transient ischemic attack (TIA) and strokes. Third, additional cardiovascular 
risk factors may frequently co-exist and exert an additive effect on the ischemia outcome 
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(hypertension, diabetes, atherosclerosis, and aging). Finally, standardized and validated 
neuroimaging  methods to study collateral circulation are still lacking 1,2.  
By contrast, inbred mice, minimizing genetic, epigenetic and environmental factors, offer a 
unique window into the brain collateral circulation plasticity 3,4,5. Nevertheless, only few 
studies described collateral circulation in mice, mainly focusing on posterior communicating 
arteries (PcomAs) and leptomeningeal arteriole variability in different mouse strains 2. 
Particularly, variability in the in the extension of the collateral circulation in terms of collateral 
number and diameter has been reported between C57BL/6 and BALB/cByJ that display high 
and low extent of collaterals, respectively, resulting in significantly different infarct volumes 
6. 
On the other hand, intrastrain dynamic PcomA patency and the hemodynamic response of 
the whole brain collateral circulation to compensate PcomA variability remains largely 
unexplored. 
This study aims to provide a comprehensive description of the macro and microcollateral 
artery plasticity during brain acute and subacute hypoperfusion in two experimental mouse 
models (MCAO and BCCAS).Therefore, we applied a combination of complementary 
techniques (T2 weighted magnetic resonance imaging [T2-MRI], arterial spin labeling cerebral 
blood flow [CBF], magneto resonance angiography [MRA] and histology) to study two 
C57/BL6J background brain hypoperfusion mouse models, where hypoperfusion is the result 
of either bilateral CCA stenosis (BCCAS) or 60 minute unilateral blockage of the left MCA with 
permanent occlusion of CCA and ECA (MCAO). 
Our study may provide potential insights that could be translated into the clinic, both in terms 
of a more informed use of these experimental models and better understanding of the brain 
collateral circulation. 
MATERIAL AND METHODS 
Animals, experimental design and exclusion criteria  
Experiments were approved by the Landesamt für Gesundheit und Soziales and conducted 
according to the German Animal Welfare Act and ARRIVE guidelines 
(https://www.nc3rs.org.uk/arrive-guidelines). 34 and 18 male C57/BL6 J mice (purchased at 
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8 weeks of age, Charles River, Germany and 10 weeks of age Janvier France, respectively) 
were housed in a temperature (22±2°C), humidity (55±10%), and light (12/12-hour light/dark 
cycle) controlled environment. The animals underwent hypoperfusion between 9 and 13 
weeks of age (n=42, BCCAS= 27, MCAO= 15) or were used as controls (naïve=7; MCAO 
sham=3) (FigS1 A, B) 
The only exclusion criterion was death during MRI due to wrong placement of the animal in 
the scanner and led to exclusion of 2 MCAO and 2 sham animals (MCAO group), resulting in 
final analyzed sample size of MCAO = 13 and MCAO sham =1. 
BCCAS mice were imaged before surgery, 24 hours and 1 week post-surgery. The BCCAS data 
from 7 weeks are data from a previous study7 focused on the same BCCAS model that we 
used because we sacrificed our BCCAS mice after 7 days. They are important to show that 
after 7 weeks, the CBF recovery is associated to a complete CoW loop detected on MRA, 
analogously to the pre-surgery condition. MCAO mice were imaged 24 hours, 1week, 4 weeks 
and 7 weeks post-surgery for angiography and estimation of cerebral blood flow (CBF) using 
arterial spin labeling. At 2 days and 8 days (BCCAS) and 7 weeks (MCAO) tissue was processed 
for immunohistochemistry 
Histology 
PFA perfused brains were cut into 50-µm-thick sections on a cryostat. After washing with 
phosphate-buffered saline (PBS), free-floating sections were incubated with 10% normal goat 
serum (NGS, GeneTech, GTX27481) and 0.1% Triton-X-100 (Sigma-Aldrich, X100) in PBS for 1 
h at room temperature to block unspecific binding. Primary and secondary antibodies were 
diluted in 1% NGS and 0.1% Triton-X-100 in PBS. Sections were incubated with rat anti-GFAP 
primary antibody (Millipore, 345860) for astrocytes and rabbit anti-Iba-1 primary antibody 
(Wako Chemicals, catalog #019-19741; RRID: AB_839504) for microglia and macrophages at 
4°C overnight. After thorough washing, sections were incubated at room temperature with 
AlexaFluor-594- conjugated goat anti-rat (anti-GFAP, Invitrogen, catalog #A11081) and 
AlexaFluor- 488-conjugated goat anti-rabbit (anti-Iba-1 Invitrogen, catalog #A11034) 
secondary antibodies for 2 h at room temperature. WGA Alexa Fluor 680 conjugate anti-lectin 
together with Evans Blue was used to stain blood vessels (further details in supplemental 
materials and methods). Nuclei were counterstained with DAPI (Fluka, 32670). Sections were 
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mounted with anti-fading mounting medium Shandon Immuno Mount (Thermo Scientific, 
9990402) on Super Frost Plus glass slides (R.Langenbrinck, 03-0060). Microphotographs were 
taken with a confocal microscope (Leica TCS SPE; RRID: SciRes_000154). 
Methods to prevent bias, statistics. 
This is an exploratory, descriptive study. Sample sizes were not based on a priori power 
calculation. Only descriptive but no test statistic was used. Mice were randomized to receive 
hypoperfusion.  
PcomA size 
Following Martin et al. 8 , we  grade the PcomA patency in hypoperfused mice, using the ratio 
between PcomA and basilar artery (BA) diameters. Martin and colleagues identified 4 PcomA 
classes in naïve mice:  1) PcomA <10% of BA; 2) PcomA 11-20% of BA; 3) PcomA 21-30% of BA 
and 4) PcomA >30% of BA. Although we are convinced that PcomA patency is a functional 
phenotype that can only be observed after PcomA recruitment, we kept the same 
classification for hypoperfused mice, where both PcomA and BA diameter are increased, 
leaving, to different extents, the PcomA/BA ratio likely similar to the one observed in naive 
mice. Based on our experiments, class 1 and class 2 have been detected either in naïve mice 
or MCAO and BCCAS mice that died few hours post-surgery, strongly arguing for a non-patent 
PcomA. Therefore, we identify class 1 and class 2 as ´non-patent´, class 3 as ´small ´, class 4 as 
´prominent´ and introduce a fifth class, represented by PcomA>60% of BA, described as ‘very 
prominent’. 
The diameters of the PcomAs were measured at the smallest point and the diameter of the 
BA was measured proximal to the superior cerebellar arteries both for the Evans Blue and 
fluorescent WGA stainings with ImageJ. The diameter of the PcomAs as a percentage of the 
diameter of the BA was calculated and used in the analysis as previously described 8 (FigS2 A, 
B). 
Angiotool 
Vascular density, vessel length, end points, total vascular junctions and junction density  were 
calculated for both striatal, cortical and leptomeningeal microvessels, selecting always the 
same regions of interest (both in terms of brain area in both hemispheres and region of 
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interest dimension) by using the software AngioTool v 0.6a as previously described (FigS2 C, 
D) 9 
Additional information are included in the supplementary materials. 
RESULTS 
Macrocollaterals (PcomAs, AcomA and ECA branches) in BCCAS and MCAO mice 
In this study we used two inbred hypoperfusion mouse models (BCCAS and MCAO) (FigS1 A, 
B) with C57Bl/6J background to describe and analyse collateral artery plasticity in response 
to acute and chronic brain hypoperfusion.  
We show that in naïve mice PcomAs are very small and not identifiable on MRA, basilar artery 
and posterior cerebral arteries, respectively affluents and effluents of PcomAs, are subtle 
(Fig1 A, FigS3 A). By contrast, in presence of an acute focal ischemia PcomAs become 
prominent vessels up to ≈60% of the basilar artery diameter. Their recruitment in the first 
hours post-surgery is essential for the mouse survival and CBF sustainment and it is 
characterized by an increasingly intense MRA signal (Fig1 C, D; Fig2 A-C; FigS3 B-D). These 
MRA findings have been confirmed with anatomical ones (Evans Blue and WGA CoW stainings 
in naïve, BCCAS and MCAO mice)(Fig 1 A-D; Fig 3 G, M; Fig S2 A, B; Fig S3) 
 
Among the nodes of the collateral artery circuit (anterior communicating artery [AcomA], 
PcomAs, ECA, ophthalmic artery and leptomeningeal vessels and other deep microcollaterals) 
PcomAs display a different degree of patency, critically influencing the ischemic lesion 
volume, resolution and overall CBF recovery. The atresia of the PcomA ipsilateral to the MCAO 
and the hypoplasia of one PcomA together with the late recruitment of ipsilateral external 
carotid artery retrograde flow in BCCAS are likely responsible for lethal strokes affecting up 
to 34% of one hemisphere (12/27 [44.4%] and 3/13 [23%] mice in BCCAS and MCAO, 
respectively)(Fig1 E-J)  
On the other hand, the presence of small to very prominent PcomAs  (15/27 (55.5%) and 
10/13 (77%) BCCAS and MCAO mice, respectively) guaranteed the survival during the most 
severe hypoperfusion (one day post-surgery, ≈70-80% CBF drop) (Fig1 E-F; FigS3 B-D). 
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Moreover, in a minority of mice the collateral recruitment was particularly rapid and effective, 
leading to no lesions (defined as white or gray matter hyperintensities) detectable on T2 MRI 
during the first week post-surgery (BCCAS 2/27 [7.4%], at least 1 prominent PcomA together 
with bilateral recruitment of ECA retrograde flow 1 day post-surgery) (Fig2 F; TableS1)  or 
small lesions (1-5% of the left hemisphere) confined to striatum and dorsal part of the 
prefrontal cortex (MCAO, 7/13 [53.8%], prominent/very prominent left PcomA) (Fig3 A, O). 
BCCAS ( 30% stenosis of both CCAs: left CCA stenosis [surgery day 1], right CCA stenosis 
[surgery day 2]) 
BCCAS is the result of a 2-day surgery beginning first with a left CCA stenosis of approximately 
30% and after one day with the stenosis of the right CCA (FigS1 A). The compensatory 
mechanisms activated at day 1 deeply affect also day 2 outcome. The CBF reduction in the 
left hemisphere 1 day post-surgery reaches  an average of 72% (20%-98%) in left striatum and 
frontal cortex (Fig2 G; TableS2; TableS3).This severe CBF drop likely instantly recruits a) left 
PcomA, b) AcomA and c) left ECA retrograde flow (Fig2 A-B). The AcomA likely redistributes 
blood flow from the right to the left hemisphere, with an overall reduction of right CBF and a 
consequent increased vulnerability for ischemic lesions during the surgery on this remaining 
side. Indeed, 1 day post-surgery, arterial border zones between right ACA and right MCA were 
the most susceptible areas (Fig2 Ba; FigS4; FigS5). 
20/27 mice (74%) presented small to moderate ventral subcortical lesions affecting  overall 
1%-37% of the right hemisphere and particularly, right striatum (17/20 [85%]), prefrontal 
cortex (14/20 [70%]), hippocampus (10/20 [50%]), corpus callosum (5/20 [25%]) (Fig2 H; 
TableS4). These lesions were associated with a right CBF reduction which was more severe 
(82% [range: 60%-95%]), compared to the one observed in the left side (Fig2 G; TableS2; 
TableS3) and to the absence of retrograde flow from right ECA, which, on the contrary, was 
already present in the left side (Fig2 A-B). 
Recruitment of retrograde flow from ECA and PcomA patency are the main factors influencing 
CBF and therefore lesion extension and overall recovery (Fig1 F,J; Fig2; FigS5). However, the 
significant intra-strain variability of PcomAs and ECA retrograde flow recruitment lead to 
markedly different degrees of hypoperfusion. Among the mice with at least one patent 
PcomA, surviving during the first week post-surgery (15/27 [55.5%]), we identified three main 
neuroimaging and vascular phenotypes: 1) mice presenting small subcortical lesions, 
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generally affecting right watershed areas (5%-20% of the right striatum and corpus callosum, 
10/15 [66.6%]), displaying at least one prominent and one small PcomAs and retrograde flow 
from left ECA at day 1(Fig2 A-C, D; FigS5 A; TableS1); 2) mice presenting different degrees of 
ischemic lesions in the left hemisphere (3/15 [20%]), associated to absence of retrograde flow 
from left ECA and 1 prominent PcomA  (Fig2 E; FigS5 B; TableS1) and 3) mice with no ischemic 
lesions both at one day and 7 days post-surgery (2/15 [13.3%]), displaying at least one 
prominent PcomA and retrograde flow from both ECAs   (Fig2 F; FigS5 C; TableS1). 
Importantly, even if the CBF drop may not cause ischemic lesions detectable on T2 MRI, mild 
hypoperfusion leads to migration and activation of microglia/macrophages and astrocytes 
(FigS6). 
 
External-internal carotid shunt via ophthalmic artery in BCCAS mice  
Although we could not assess the ophthalmic artery flow using a Doppler, we have used 
angiography and histology to study the retina. Seven days post-surgery, we report severe 
retina degeneration with gliosis particularly in the ganglion cell layer and moderate loss of 
presynaptic protein CTBP2 in the outer plexiform layer. During chronic hypoperfusion we 
observe severe thinning and retinal atrophy mostly in the ganglion cell layer and inner nuclear 
layer, with significant reduction of CTBP2 signal (FigS7 A-C). Despite the recruitment of 
ancillary branches of the ECA and a likely external-internal shunt, as already reported in 
patients with internal carotid occlusive disease 10,11, we show that retinal degeneration is 
irreversible and this is likely due to either the late recruitment of retrograde flow through the 
ECA or the pre-existence of external-internal carotid shunt (retrograde flow from the eye to 
the brain) via ophthalmic artery or both with an overall reduction of blood flow to the retina. 
MCAO (Left MCA, CCA and ECA occlusion) 
MCAO is the result of surgery consisting in the 60 minute transient blockage of left MCA and 
permanent occlusion of CCA and ECA (all in one session) (FigS1 B). This causes a significant 
drop in CBF in the ipsilateral hemisphere. One day post-surgery the average CBF reduction is 
≈60% (range: 22%- 81%) in ipsilateral striatum and frontal cortex (TableS5, S6). This acute and 
severe hypoperfusion, likely causes a hemodynamic gradient between anterior hypoperfused 
brain areas and posterior areas normally perfused. The blood flow in left PcomA and the more 
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intense AcomA signal, detected 1 day post-surgery on MRA, is an indirect indication of left 
PcomA and AcomA patency (Fig3 C-F and K, L). A new global and stable hemodynamic balance 
close to the baseline is reached in 9/10 (90%) mice seven days post-surgery (Table S5) and 
left PcomA and AcomA from ancillary vessels became critical vessels (Fig3D-G, K-L; FigS8 A).  
Despite this general pattern, high intra-strain variability of PcomA patency is the most 
important factor in determining the stroke outcome. Indeed, it significantly influences the 
lesion volume, the lesion extension, the CBF recovery and the contralateral drop in CBF (Fig3 
O-R; Table S6, S7). In our cohort we report a spectrum of left PcomA sizes, from non-patent 
and small (Fig3 M, 4/13 (30.7%) and 2/13 (15.4%), respectively) to promiment and very 
prominent (Fig3 G, 6/13 (46%) and 1/13 (7.7%), respectively). Mice with left non-patent 
PcomA died within few hours post-surgery. MCAO mice with a small left PcomA (Fig3 M; S8 
B) displayed the largest lesions affecting up to 34% of the left hemisphere (Fig3 B) and 
including also dorsal areas (orbital cortex and cerebellum) (Fig3 B, O, P; Table S8), the most 
severe drop in CBF (up to 80% in left striatum) (Fig3 Q, R), the slowest recovery (up to 4 weeks) 
(TableS5) and a marked brain atrophy (Fig3 N). In these mice, we observed a significant 
proportional compensatory decrease of contralateral CBF (up to 30% in right striatum, Fig3 
Q). In comparison, mice with prominent left PcomA (FigS8 A) showed lesions 2.6 times smaller 
(Fig3P; TableS7), mostly affecting ventral areas (prefrontal cortex, striatum and ventral 
hippocampus) (Fig3 O) and a moderate drop in ipsilateral and contralateral CBF (≈57% and 
15% in left and right striatum, respectively) (Fig3 Q). Very prominent PcomA (Fig3 G) was 
associated to the smallest lesions (5% of the left hemisphere) (Fig3 A), mild CBF reduction and 
more rapid recovery (Fig3 Q, R) and absence of macroscopic ipsilateral brain atrophy (Fig3 H) 
In the supplementary we describe in details the extreme phenotypes. The other cases fall 
within this phenotypic spectrum (FigS8) 
The hemisphere contralateral to MCAO 
In MCAO mice, the blood flow redistribution from the right to the left hemisphere via AcomA 
causes a significant and proportional CBF reduction in the right hemisphere: 17% (range: 4%-
33%), 28% (range:18-41%) in striatum and frontal cortex, respectively (Fig3 Q; TableS5, S6). 
Interestingly, MCAO mice with small left PcomA display significantly lower global CBF values, 
both for the left and right hemisphere at day one (Fig3 Q; TableS5, S6) and right CBF reduction 
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(≈30% in right striatum) which is close to the CBF reduction seen in BCCAS mice with the most 
effective vascular phenotype (retrograde flow from both ECAs and 2 prominent PcomAs) 
(≈40%) at day 7 (TableS6, S3). This pattern mimics the hemodynamic effects of unilateral CCA 
stenosis and therefore triggers analogous compensatory mechanisms such as right ECA 
retrograde flow, although temporarily and only during the first 24 hours post-surgery (FigS8 
C). On the contrary, a more stable involvement of the contralateral hemisphere is evident at 
the microvascular level (leptomeningeal arterioles and deep microvessels), where increased 
number of larger arterioles and  a more dense vascular network is detected in the infarct and 
peri-infarct areas, respectively, 7 weeks post-surgery (Fig4, 5, 6). 
Microcollaterals (leptomeningeal and deep arterioles) in BCCAS and MCAO mice 
In both models part of the microvessels likely represent microcollaterals, given the increased 
number of vessel length, vascular junctions and reduction of end points compared to naïve 
mice (Fig5E-G). These microvessels display in the cortical and deep gray matter a similar 
pattern whereas white matter arterioles appear significantly rare and sparse (Fig4, 5; FigS9; 
FigS10) 
Infarct and peri-infarct areas and other hypoxic regions are characterized by significantly 
different microvascular features. Increased size up to 50μm diameter and reduced density of 
arterioles are a hallmark in the infarct area(Fig4 A-CIV; TableS9). Their increased diameter is 
associated with a significant invasion of microglia/macrophages, generally in the form of islets 
(Fig4 CI, CII) during the hypoxic subacute phase whereas activated astrocytes are detected in 
the peri-infarct area and delimit the infarct-peri-infarct border (Fig4 CIII). By contrast, the 
peri-infarct area and moderately hypoperfused regions are characterized by a network of 
microvessels with moderately increased length and whose number of anastomoses is 
proportional to the degree of hypoperfusion (highest density of junctions in right and left 
hemisphere in BCCAS and MCAO mice, respectively)(Fig5 E; Table S10).Importantly, in MCAO 
this phenomenon affects also the relatively hypoperfused hemisphere contralateral to the 
focal ischemia and at the leptomeningeal superficial level gives rise to a symmetric picture, 
with both right and left leptomeningeal vessels presenting overlapping vascular anastomoses, 





The aim of the study was to capture the collateral vessel evolution during brain ischemia and 
to comprehensively describe the hemodynamic changes over time (2 days, 7 days, 4 and 7 
weeks) in 2 widely used experimental models of brain hypoperfusion with C57/BL6 J 
background: MCAO and BCCAS.  
We show that contralateral hemisphere, vertebrobasilar circulation and retrograde flow from 
ECA represent 3 essential reservoirs for the CBF redistribution during focal ischemia. In 
presence of acute ischemia, these 3 pools, normally independent, are interconnected by 
AcomA, PcomAs and ECA ancillary branches and become a pivotal and integrant part of the 
same hemodynamic circuit. Moreover, the partial functional overlap between them leaves 
the possibility for some backup solutions.  
PcomAs are the main determinants of stroke survival in MCAO. First, MCAO mice with 
no/non-patent PcomAs die within 24 hours post-surgery. Second, MCAO mice display lesion 
volume, lesion resolution and ipsi and contralateral CBF reduction proportional to the left 
PcomA calibre, with mice with small and very prominent PcomAs showing the biggest and 
smallest lesion volumes and least and most effective lesion resolution, respectively(Fig3). 
Analogously, PcomA patency together with the promptness of ECA retrograde flow 
recruitment play a key role in BCCAS.  
Overall, in both these hypoperfusion mouse models we report a similar percentage of PcomA 
variability with 15.4% and  37% mice with none or 2 non-patent PcomAs, 30.8% and 22.2% 
mice with at least 1 small PcomA, 53.8% and 37%  with one prominent/very prominent PcomA 
and 33.3%  mice with 2 prominent PcomAs. By contrast, McColl et al reported in the same 
C57BL/6 strain  3/10 (30%), 6/10 (60%) and 1/10 (10%) mice with none, one and 2 PcomAs, 
respectively 3.This difference may be due to 3 main factors: first, McColl studied the collateral 
status in naïve mice and we show that collaterals are recruited under moderate-severe acute 
hypoxia, therefore representing a functional vascular phenotype that can only be seen in 
response to ischemia. Thus, the presence of very subtle vessels in naïve mice does not imply 
their potential patency. Second, the small sample size that can significantly bias the results. 
Third, PcomAs size represents a dynamic spectrum, varying significantly from non-patent to 
very prominent and therefore an unambiguous classification is difficult to draw.  
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A growing body of evidence reported hemodynamic, metabolic, neuroimaging and functional 
changes in the stroke contralateral hemisphere in the acute phase (first hours-days post 
ischemia) 12,13,14,15,16. Here, we provide evidence that the contralateral hemisphere represents 
an important reserve of blood flow that can be shifted to the ischemic focus, to 
counterbalance any CBF gradient. First, the average reduction of right CBF in the BCCAS model 
(≈83%) is higher compared to the hypoperfusion detected in left hemisphere (≈72%), likely 
due to the pre-existent right to left CBF shunt due to the surgery on left CCA at day 1, the left-
right CBF gradient drop and the later recruitment of the right ECA. Consequently, the right 
ACA territory and the border zones between right MCA and right ACA become particularly 
susceptible to ischemic lesions (Fig2 Ba; FigS4 and S5). Second, MCAO right CBF reduction is 
proportional to the reduction of CBF in the left hemisphere and thus to the left PcomA calibre 
(Fig3 Q; TableS6). This is in line with previous studies in patients that measured CBF with 
positron emission tomography (PET) and found a significant correlation between flow 
impairment in the ischemic area and proportional CBF reduction in the contralateral 
hemisphere 12. Third, the CBF drop in MCAO mice with small left PcomA(up to 37% of the pre-
surgery value) is very close to the CBF reduction seen in BCCAS mice with two prominent 
PcomAs and retrograde flow from both ECAs 7 days post-surgery (≈ 40%) (TableS3, S6). 
Therefore, this simulates the hemodynamic effects of a CCA stenosis and thus temporarily 
triggers the same compensatory mechanisms such as right ECA retrograde flow (FigS8 C). 
Moreover, the critical importance of the contralateral hemisphere in the sustainment of the 
CBF is highlighted by the different time of recovery between MCAO mice and BCCAS. 90% of 
MCAO mice recover almost to the baseline after one week whereas BCCAS mice take 4 weeks 
7. Finally, the significant involvement of the contralateral hemisphere leads to a moderate 
hypoperfusion that even if it is not sufficient to cause ischemic lesions and remains below the 
threshold of T2 weighted MRI detectability, is responsible for a significant microvascular 
remodelling at different levels: from the superficial leptomeningeal to the deep striatal layers 
(Fig5; Fig6).  
Analogously to the peri-infarct area, moderately hypoxic ipsilateral and contralateral areas 
are covered with a dense network of microvessels with moderately increased length and 
significantly augmented anastomoses (Fig5). Given its hemodynamic features, this 
microvascular phenotype likely results in a greater perfusion volume thus improving the 
tissue oxygenation and the uptake of catabolites. Moreover, this vascular web likely exerts a 
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trophic function through the synthesis and release of neurotrophins such as NGF, IGF-I, and 
BDNF, that further catalyse the long-lasting vessel formation and recruitment of immune cells 
17. Therefore, this hypoxia-triggered-vascular plasticity may shape and significantly influence 
pre-existent neuronal circuits, explaining neurophysiologic changes also in the contralateral 
hemisphere 18.  
By contrast, and as already reported in stroke patients 19, the infarct area is characterized by 
rarefied arterioles with increased diameter, up to 4.5 times the diameter of the largest 
arterioles observed in the respective brain regions in naïve mice (Fig4; TableS9). These 
vascular features assure a reduced resistance and are particularly effective for a rapid delivery 
of microglia/macrophages, removing debris and exerting a neuroprotective function in the 
subacute phases (7 days post-surgery) (Fig4 CI, CII) 20,21. 
In addition, the abrupt redistribution of blood in ancillary vessels or vessel normally 
characterized by lower intravascular pressure causes macromodifications such as increased 
tortuosity, which is a hallmark of intravascular hypertension (Fig3M, blue arrow; FigS8 A,B) 
22,23. Over time, this may lead to 1) arteriolar ialinosis in microvessels 24, with an increased risk 
for subcortical microbleeds, already reported in the same BCCAS model, 6 months post-
surgery 7 and differing from amyloid related microbleeds, given the main subcortical location 
and the absence of lobar involvement 25 and 2) aneurisms in macrovessels 22,23. Therefore, 
strengthening a possible cause-effect link between ischemic and haemorrhagic strokes, 
supported already by several genetic risk factors such as COL4A1 associated to both 26,27. 
Finally, we showed that the BCCAS model, which has been used as an experimental model of 
chronic hypoperfusion is firstly characterized by an acute and severe hypoperfusion leading 
to the rapid vascular response and ischemic lesions particularly affecting subcortical and 
watershed areas (striatum, corpus callosum and prefrontal cortex). The acute hemodynamic 
compensatory response leads to a gradual recovery and in the long-term a modest 
hypoperfusion. Therefore, BCCAS mice significantly differ from patients, where chronic 
hypoperfusion is a gradual phenomenon, occurring in years or decades and leaving the time 
for a progressive adaptation of collateral circulation both at the level of the circle of Willis and 
leptomeningeal collaterals. The compensatory responses triggered during this acute and most 
severly hypoperfused phase (1 day) are the main determinants of the long-term outcome 
both in terms of lesion volume, extension, recovery and brain atrophy. Thus, the loss of 
neurons reported in corpus callosum in the chronic phase in this BCCAS model 28 may be 
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attributable to ischemic lesions and acute severe drop in CBF, rather than resulting from 
chronic mild global hypoperfusion.  
In summary, we show that focal ischemia triggers a global hemodynamic response, 
significantly affecting also the contralateral hemisphere until the effective re-establishment 
of a new hemodynamic balance. Acute hypoperfusion immediately leads to a negative 
selection of mice with no PcomAs. PcomA patency ipsilateral to the focal ischemia decides 
the infarct volume and recovery in MCAO mice. Similarly, the rapidity of retrograde ECA blood 
flow recruitment, together with PcomA patency, mainly shape the extension and the side of  
ischemic lesions in BCCAS mice. Finally, given the significant intrastrain collateral variability, 
when using C57/BL6J mice as MCAO and BCCAS ischemia models to test the independent 
effect of neuroprotectants and genes on stroke outcome, PcomAs and the overall collateral 
recruitment particularly during the most severe brain hypoperfusion (1-7 days post-surgery) 
have to be critically considered as additive and main factors influencing brain lesions and 
perfusion recovery.  
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 LEGENDS 
Fig1 
PcomA and vascular phenotype effect in MCAO and BCCAS mouse models. A-D. PcomA 
calibre in normal and ischemic conditions. A. Non-patent right PcomA (2a), detected in a naïve 
mouse; B non-patent right PcomA (2a) and absence of left PcomA (2b) in MCAO sham; C 
prominent left PcomA (2b) and non-patent right PcomA (2a) in MCAO; D 2 prominent PcomAs 
in BCCAS (2a, 2b). 1, basilar artery (BA); 2a, right PcomA; 2b, left PcomA; 3a, right posterior 
cerebral artery (PCA); 3b, left posterior cerebral artery (PCA). The numbering of the vessels 
reflects the direction of the collateral blood flow following focal ischemia in the MCA or 
anterior brain areas: BA→PcomA→PCA, as already described in detail in the BCCAS and MCAO 
models in Fig S1 A and B. E-F Effect of left PcomA size and PcomA-ECA retrograde flow in 
MCAO and BCCAS survival. MCAO mice with non-patent left PcomA die few hours post-
surgery. ≈ One-fourth of mice with small left PcomA die within one day post-surgery. The 
majority of MCAO mice with small left PcomA and all the MCAO with prominent/very 
prominent PcomA survive (E). Analogously, BCCAS mice with no PcomAs or no PcomA-no 
ipsilateral ECA retrograde flow die within few hours post-surgery. By contrast, BCCAS mice 
with at least one small to prominent PcomA and retrograde flow from left or right ECA do 
survive. G-H MCAO mice with non-patent left PcomA died within 1 day  post-surgery with 
ischemic lesions affecting more than 35% of the left hemisphere and left PcomA and overall 
left blood flow were not identifiable on MRA one day post-surgery. I-J. BCCAS with non-patent 
right PcomA (*) and absence of right ECA retrograde flow recruitment (**), presenting severe 
ischemic lesions affecting >20% of the right hemisphere. 
Fig2 
MRA and MRI phenotypes in BCCAS mice 1-7 days post-surgery. A-C. Vascular collateral 
plasticity during the first week post-surgery; a, circle of Willis; b, ECA flow  A. Pre-surgery 
MRA, where PcomAs are not identifiable. B MRA 1d post-surgery, showing recruitment of 
both PcomAs (white arrows), directing the blood flow to the PCAs, whose MRA intensity is 
increased,  and left ECA retrograde flow (green arrow, yellow dashed line) and hypoperfused 
border zones between right ACA and right MCA (a, orange arrow). C. MRA 7d post-surgery, 
characterized by increased PcomA (white arrows) and PCAs MRA intensity signal, recruitment 
of right ECA retrograde flow (green arrow, yellow dashed line), with a compensatory 
sustainment of the right anterior cerebral artery (ACA) territory (a, orange arrow) partially 
coming from the left hemisphere through the AcomA (blue dashed line). D-F. Main ischemic 
lesion patterns observed in BCCAS 24h post-surgery on T2-weighted MRI: small right 
subcortical lesions (D), big cortical and subcortical lesions (E) and no lesions detectable (F). G. 
Percentage of CBF reduction at day 1 in BCCAS mice in left and right hemispheres, displaying 
more accentuated hypoperfusion in the right hemisphere, particularly in the frontal cortex. 
H. Most affected brain regions in the BCCAS model 1 day post surgery are the watershed areas 
between right ACA and right MCA: right cerebral cortex, corpus callosum, striatum und 
18 
 
hippocampus. CCA L, left common carotid artery;  ECA L, left external carotid artery; ECA R, 
right external carotid artery; PCA L, left posterior cerebral artery; PCA R, right posterior 
cerebral artery;  PcomA L, left posterior communicating artery; PcomA R, right posterior 
communicating artery. R, right; L, left. Pre-Op, pre-surgery. 
Fig3 
Effect of PcomA in MCAO. A-B, ischemic lesions (red shades) identified on T2-weighted MRI.  
A-N Edges of the phenotypic spectrum observed in MCAO mice: small lesion (A) associated to 
very prominent left PcomA (C-G) and absence of macroscopic left atrophy (H). C-D, 
recruitment of left PcomA is identifiable on MRA 1 day post-surgery (white arrow) and it is 
accompanied by increased intensity of left PCA (blue arrow). B, Extensive lesion caused by 
small left PcomA (I-M), leading to significant left brain atrophy (N). E-F and K-L progressive 
increase in the AcomA size (yellow arrows). O-R PcomA size is the most important factor in 
determining lesion volume during acute hypoperfusion (1d), infarct resolution during 
subacute hypoperfusion (7d) (O, P, Q), ipsilateral and compensatory contralateral CBF decay 
in ventral ischemic regions such as striatum (Q, R). Detailed description of MCAO mice 
phenotype as well as collateral blood flow direction are provided in the supplementary 
materials. Small, prominent and very prominent refer to the left PcomA size. SL, striatum left; 
SR, striatum right; d, day/s; w, weeks. 
Fig4 
Microvascular plasticity in the infarct area in MCAO and BCCAS models. The infarct area is 
characterized by arterioles reduced in number and increased in size both at the 
leptomeningeal level (A) and striatal one (B-CIV)(white arrows), generally associated in the 
subacute phase (7d) to significant microglia infiltration (CI-CII). Scale bars: B, CI, CIII, CIV = 
1mm; B', CII = 0.5mm. Mice perfused with WGA Alexa Fluor® 680 conjugate (Termofisher, 
W32465).D, day/s; wk, weeks. 
Fig5 
Moderately hypoperfused areas are characterized by microvessels with moderately increased 
length in MCAO compared to naïve mice (A-D’, F), whose significantly increased number of 
anastomoses (E-G) is proportional to the degree of hypoperfusion at day 1(H). A-B’ and C-D’. 
Microvessels stained with WGA in left and right striatum in naïve and MCAO mice, 
respectively. A’-B’ and C’-D’, angiotool analysis of the homologous histological sections (A-B 
and C-D). Mice perfused with WGA. Scale bars = 0.5mm. Alexa Fluor® 680 conjugate 





A-F. Leptomeningeal vessels in MCAO mice 7 weeks post-surgery. Leptomeningeal vessels 
in naïve mouse (A) and MCAO (B). C. Anastomoses between terminal branches of PCA and 
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MCA in the right cortex of MCAO mice. MCAO mice are characterized by a symmetric network 
of leptomeningeal arterioles with increased anastomoses (D), density (E) and moderately 
increased vessel length (F), both in cortex ipsilateral and contralateral to MCAO. MCA, middle 























SUPPLEMENTARY MATERIALS AND METHODS 
 
BCCAS 
Anaesthesia was achieved using isoflurane in a 70:30 nitrous oxide:oxygen mixture and core body 
temperature was maintained at 37 ± 0.2 °C with an automated rectal probe and heat blanket. A 
midline incision was made in the neck, and a carotid artery was carefully exposed. Hypoperfusion was 
induced by winding a custom ordered, non-magnetic, surgical grade microcoil (160 µm inner diameter, 
Shannon Coiled Springs Microcoil, Limerick, Ireland) around one of the carotid arteries. The muscle 
and glands were guided back into place and local anaesthetic was applied to the sutured wound prior 
to recovery. Twenty- four hours later, the same procedure was repeated on the other carotid artery. 
This delay represents an important refinement that does not result in higher mortality when using the 
smaller sized microcoils. Regular diet was placed on the floor of the cage to assist with feeding. In the 
BCCAS model, hypoperfusion was induced by winding a custom ordered, nonmagnetic, surgical grade 
microcoil (160 μm inner diameter; Shannon Coiled Springs Microcoil, Limerick, Ireland) around one of 
the common carotid arteries. The muscles and glands were guided back into place, and local 
anesthetic was applied to the sutured wound before recovery. Twenty-four hours later, the same 
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procedure was repeated on the other common carotid artery. This delay represents an important 
refinement that does not result in higher mortality when using the smaller sized microcoils.  
MCAO 
In the MCAO model, hypoperfusion was induced as described previously 
(http://precedings.nature.com/documents/3492/version/2). Briefly, after closing the left common 
carotid artery (CCA) and left external carotid artery (ECA) a microvascular clip was put on the left 
internal carotid artery (ICA) and a small incision was made on the CCA. A nylon filament (7019PK5Re, 
Doccol Corp, Redlands, California, USA) was introduced over CCA and ICA to occlude the origin of 
middle cerebral artery (MCA) and fixed with a suture around the ICA. After 60 minutes, the filament 
was removed causing immediate reperfusion. Afterwards the suture on the ICA was closed. This type 
of MCAO surgery results in permanent occlusion of left CCA, ECA and ICA.   
MRI measurements  
Anaesthesia was again achieved using isoflurane as per above, and body temperature and respiration 
rate were monitored with MRI compatible equipment (Small Animal Instruments, Inc., Stony Brook, 
NY).   
 
 
Cerebral blood flow and angiographies 
CBF and angiography were measured on a 7 T Pharmascan using Paravision 5.1 software (Bruker 
BioSpin, Ettlingen, Germany). For the CBF measurement, radio frequency transmission was achieved 
with a 72 mm diameter quadrature resonator actively decoupled to a mouse quadrature surface coil 
used for reception (Bruker BioSpin, Ettlingen, Germany). A single slice (1 mm) flow-sensitive 
alternating inversion recovery (FAIR) sequence with a rapid acquisition with relaxation enhancement 
(RARE) readout was used (repetition time (TR)/recovery time/echo spacing (ΔTE)/effective echo time 
(TEeff): 12 000/10 000/7.2/35.9 ms, respectively, 16 inversion times (35-1500 ms), RARE factor: 32, 
inversion slice thickness: 4 mm, 180° hyperbolic secant (sech80) inversion pulse (20 ms), field of view 
(FOV): 25.6 mm2, matrix: 128 x 64 enlarged by partial fourier transform to 128 x 128, resolution: 200 
µm2, 12 min).  For angiography measurements, a 20 mm diameter quadrature volume coil (RAPID 
Biomedical, Rimpar, Germany) was used for radio frequency transmission and reception and a 3D time 
of light (TOF) sequence was used (TR/TE: 15/2.5 ms, α: 20 ˚, FOV: 25 mm3, resolution: 98 x 130 x 196 
µm3 zero-filled to 98 µm3, 6 min). Spectroscopy, T2 weighted and MR spectra were acquired on a 7 T 
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Biospec with a cryogenically cooled transmit/receive surface coil and Paravision 6.0 software (Bruker 
BioSpin, Ettlingen, Germany).   
 A 2D RARE T2 sequence was used for anatomical images (TR/ΔTE/TEeff: 3100/11/33 ms, RARE factor: 
8, 29 consecutive slices, slice thickness 0.45 mm, FOV: (16.2 mm)2, resolution: 100 µm2, NA: 2, 2 min 
4 s). A stimulated echo acquisition mode (STEAM) sequence was used for spectroscopy following local 
shimming (MAPSHIM) across a cubic 8 mm3 voxel placed in the striatum (TR/TE/mixing time: 2500 
ms/3 ms/10 ms, number of averages (NA): 256, VAPOR water suppression, 10 min 40 s). 
 
MRI Data Analysis  
CBF maps were calculated using the Perfusion ASL macro in Paravision 5.1 software via the 
T1 method using a blood T1 value of 2100 ms and a brain blood partition coefficient of 0.89 
mL/g   1,2. Analysis of the CBF values were done using a custom written Matlab toolbox for 
nonlinear atlas registration 3  was used to select the CBF slice from the volume and coregister 
the CBF  on  the T2 images. Finally T2 and CBF images were transformed into the Allen brain 
atlas space and the atlas based CBF-values were extracted for all correlating Allen brain atlas 
structures in both hemispheres.  (Release 2013a (MathWorks, Natick, MA, USA) script 
extracted the CBF maps from Paravision, and used atlas registration and coregistration of CBF 
maps in the atlas space for striatum and prefrontal cortex). The resulting CBF values were 
expressed in mL/min/100g. 
Tissue preparation and staining procedures  
At the conclusion of the experiments, mice were deeply anaesthetized with ketamine and 
xylazine and perfused through the heart with physiological saline followed by 4% 
paraformaldehyde, Alexa Fluor® 680 conjugate of WGA, Termofisher, W32465, 3% Gelatin 
(Sigma-Aldrich, G1890), 1% low melting agarose (Sigma Aldrich A4018) and 0.1% Evans Blue 
(Sigma Aldrich E2129). Whole brains were scanned with Li-cor (Li-Cor Odyssey-CLx). 
Subsequently, the brains were post-fixed for 24 hours in 4% PFA, and cryoprotected in 30% 
sucrose solution before being snap frozen in -40 ºC methylbutane. Tissue was sectioned to 50 
µm and stored in cryo-protective solution (1 part ethylene glycol, 1 part glycerine and 2 parts 





Imunohistochemistochemical analysis of retinal sagittal sections was performed  as 
previously described (Crespo-Garcia et al. PLOS ONE 2018). In short, after fixation of the eyes 
in 4% PFA and embedding in paraffin, 5um thin sections were stained for H/E, or  GFAP 
(Z0334, DAKO, Hamburg, Germany) or CTBP2 (ab128871, Abcam, Cambridge GB) at 4°C 
overnight. Subsequently the sections were incubated with fluorescence 
conjugated  secondary antibodies for 1h at RT and nuclei were counterstained with DAPI 
(Sigma, Taufkirchen, Germany). Images were digitalized using a Zeiss Axio Imager microscope 
and Zen-Lite 2012 software (Zeiss, Jena, Germany) 
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Legends supplementary figures and tables 
 
FigS1  
MCAO and BCCAS models with surgical key features and collateral blood flow during acute 
ischemia. The blue arrows indicate the direction of the collateral blood flow following the 
surgery. A. Basilar artery (BA) → superior cerebellar artery (SCA) → posterior communicating 
artery (PcomA) → posterior cerebral artery (PCA). B. Basilar artery (BA) → left superior 
cerebellar artery (SCA) → left posterior communicating artery (PcomA) → left posterior 
cerebral artery (PCA) and right anterior cerebral artery (ACA) → anterior communicating 
artery (AcomA) → left anterior cerebral artery (ACA). CCA, common carotid artery,  BA, basilar 







A-B exemple of very prominent PcomA, based on the PcomA/BA diameter ratio 
measurements both with Evans Blue and WGA stainings. C-D Angiotool analysis of 
microvessel density, average length and anastomoses at the superficial leptomeningeal and 
cortical and deep gray striatal level. Leptomeningeal and deep microvessels during 
hypoperfusion. Region of interest has been always kept the same, both in terms of dimensions 
and brain regions in both hemispheres.  Scale bar = 1mm. 
 
FigS3 
PcomAs in naive, BCCAS and MCAO mice. In the absence of a pressure gradient in the Circle 
of Willis, PcomAs (white arrows) are not recruited and appear hypoplstic and subtle, not 
detectable on MRA. Analogously, basilar artery (BA, red arrow) and PCA (yellow arrows), 
PcomA affluents and effluents, respectively, display a small diameter (A). By contrast, during 
ischemia, PcomAs become patent, progressively more prominent, and clearly detectable on 
MRA (B-D, MRI, white arrows). A Naïve mice, displaying none or non-patent PcomAs. B-C 
BCCAS mice 7 days post-surgery, displaying 2 and 1 prominent PcomAs and BA with increased 
diameter. D-E MCAO mice, 7 wks post-surgery displaying prominent and small left PcomAs. E 
MCAO mice with very subtle PcomAs and markedly increased tortuosity on the left side, 
barely detectable on the MRA  
 
FigS4 
BCCAS MRA showing Circle of Willis and ECA retrograde flow at different time points: pre-
surgery, 1 day, 7 days and 7 weeks post-surgery. A BCCAS mice pre-surgery. Complete circle 
of Willis loop (blue arrows) and absence of ECA retrograde flow (yellow arrows). B BCCAS 1d 
post-surgery. Weak MRA intensity in correspondence of ACA-MCA watershed areas (blue 
arrows). Retrograde flow from ECA (yellow arrows). C. BCCAS 7d post-surgery. Collateral flow 
recruitment and initial hemodynamic recovery of ACA-MCA territories inferable from an 
increased MRA intensity (blue arrows). D. BCCAS 7 weeks post-surgery. CBF recovery and 
return to the pre-surgery hemodynamic condition, with complete circle of Willis loop with 
persistence of ECA retrograde flow. 
FigS5 
BCCAS MRA at day 1: different pattern of ECA retrograde flow (blue arrows): only left ECA 
retrograde flow associated to contralateral small subcortical lesions corresponding to the 
right ACA-MCA border zones (A); only right ECA retrograde flow associated to contralateral 
small subcortical lesions, corresponding to the left ACA-MCA watershed areas (B) and both 
left and right ECA retrograde flow associated to no lesions detectable on T2 weighted MRI (C). 





A-E MRA (A), IBA1(B-C) and GFAP (D-E) staining of a BCCAS mouse displaying no ischemic 
lesions detectable on MRA but significant microglia and astrocytes activation in both 
hippocampi and right frontal cortex, 8 days post-surgery. Scale bars represent 1mm (B, D) and 
0.5mm (C, E) 
 
FigS7 
A-C Retina progressive degeneration during subacute and chronic hypoperfusion (8 days and 
6 months post-surgery, respectively) in BCCAS mice. A. Representative sagittal sections of the 
retina stained against glial fibrillary acidic protein (GFAP, in green) showing marked gliosis in 
BCCAS animals both at 8 days (D8) and 6 months (M6). Sham animals served as control. Nuclei 
are counterstained with DAPI (blue). Scale bar represents 50 um. B. Representative sagittal 
sections of the retina stained against C-terminal binding protein 2 (CTBP2, in red) showing 
delocalization and loss of presynaptic protein in the OPL in BCCAS animals, 8 days (D8), with 
a progressive worsening at 6 months (M6). Sham animals served as control. Nuclei are 
counterstained with DAPI (blue). Scale bar represents 50 um. C. Representative sagittal 
sections of the retina, stained with hematoxylin and eosin, displaying significant thinning and 
atrophy during chronic hypoperfusion (M6). Scale bar= 0.5mm 
FigS8 
MCAO extreme neuroimaging and vascular phenotypes: mice with prominent (A) and small 
(B, C) left PcomA. Detailed description in the supplementary 
 
FigS9 
Microllateral plasticity in hypoperfused striatum and cortex in MCAO and BCCAS mice. Scale 
bar represents 0.5mm 
 
FigS10 
White matter microvessels in naïve, MCAO and BCCAS mice showing a macroscopically 
significant reduced density of microvessels in corpus callosum (long dash lines), compared to 
adjacent gray matter, both for naïve, MCAO and BCCAS mice (A-E). Increased microvessel 




BCCAS lesion volume and percentage of left and right hemisphere affected during acute and 




CBF drop in BCCAS in cortex and striatum during acute and subacute hypoperfusion (1-7 days) 
TableS3 
Percentage of CBF reduction in BCCAS in cortex and striatum during acute and subacute 
hypoperfusion (1-7 days) 
TableS4 
Brain areas mostly affected by ischemic lesions in BCCAS at day 1 
TableS5 
CBF reduction in left and right hemisphere in MCAO 1 day, 1, 4 and 7 weeks post-surgery 
TableS6 
Percentage of CBF reduction in MCAO left and right hemisphere at day 1 
TableS7 
Lesion volume and percentage of left hemisphere affected at day 1 and 7 in MCAO 
TableS8 
Percentage of brain areas affected in MCAO mice with different PcomA patterns 
TableS9 
Arteriole diameter in the infarct area of MCAO mice and in naïve mice 
TableS10 
Microvessel features in MCAO and BCCAS hypoperfused brain areas 
TableS11 
















































































BCCAS_1 ECA (L), 2 non-patent PcomAs day 1 0,147 0% 10,61 4% day 7 0 0% 3,5 1% 
BCCAS_1 ECA (L), no PcomAs day 1 0 0% 52,9 20% day 7 / / / / 
BCCAS_2 ECAs_1 prominent PcomA (R) day 1 0 0% 10,57 4% day 7 0 0% 12,887 5% 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) 
PcomAs day 1 0 0% 9,38 4% day 7 0 0% 32,762 13% 
BCCAS_2 ECAs, 2 prominent PcomAs day 1 0 0% 10,8 4% day 7 0 0% 0 0% 
BCCAS_1 ECA (L), no PcomAs day 1 0,042 0% 42,296 16% day 7 / / / / 
BCCAS_2 ECAs, 1 prominent (R) PcomA day 1 0 0% 0 0% day 7 0 0% 0 0% 
BCCAS_1 prominent PcomA (L) day 1 0,32 0% 96,63 37% day 7 / / / / 
BCCAS_2 ECAs, 1 prominent (L), 1 small (R) 
PcomAs day 1 0 0% 22,57 9% day 7 0 0% 1,25 0% 
BCCAS_2 ECAs, 1 prominent (R), 1 small (L) 
PcomAs day 1 21,284 8% 0 0% day 7 1,109 0% 0 0% 
BCCAS_1 ECA (R), 1 prominent (L) PcomA day 1 8,545 3% 6,986 3% day 7 84,627 32% 0,001 0% 
BCCAS_1 ECA (R), 1 prominent PcomA (R) day 1 50,358 19% 0 0% day 7 / / / / 
BCCAS_1 ECA (L), 1 prominent PcomA (R) day 1 0 0% 1,176 0% day 7 0 0% 33,212 13% 
BCCAS_1 ECA (L)_2 prominent PcomAs day 1 0 0% 0 0% day 7 0 0% 19,247 7% 
BCCAS_2 ECAs, 1 prominent (R), 1 non-patent 
PcomA day 1 0 0% 0 0% day 7 0 0% 0 0% 
BCCAS_1 ECA (L)_2 very prominent PcomAs day 1 0 0% 21,667 8% day 7 0 0% 7,154 3% 
BCCAS_1 ECA (L),no PcomAs day 1 0 0% 20,227 8% day 7 / / / / 
BCCAS_1 ECA (L), 1 prominent PcomA (R) day 1 0 0% 12,07 5% day 7 0,478 0% 47,427 18% 
BCCAS_2 ECAs, 1 prominent (R) PcomA day 1 0 0% 0 0% day 7 0 0% 2,887 1% 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) 








Mouse.ID_vascular phenotype Time CBF_Cx_L CBF_Cx_R CBF_S_L CBF_S_R 
BCCAS_1 ECA (L), 2 non-patent PcomAs 0d 122,5151822 126,8046884 118,8884354 107,8328454 
BCCAS_1 ECA (L), 2 non-patent PcomAs 1d 15,80999825 8,599138384 31,83154433 19,11489724 
BCCAS_1 ECA (L), 2 non-patent PcomAs 7d 16,58669945 23,15701226 24,95434232 31,57716935 
BCCAS_2 ECAs_1 prominent PcomA (R) 0d 102,3838066 100,8180672 83,09938819 84,811758 
BCCAS_2 ECAs_1 prominent PcomA (R) 1d 49,81267848 18,44921259 40,84048021 22,33278601 
BCCAS_2 ECAs_1 prominent PcomA (R) 7d 48,34756302 28,39457039 34,29972463 33,81740931 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) PcomAs 0d 100,5850698 94,65422142 84,19319033 84,12428289 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) PcomAs 1d 38,89821156 16,68755184 36,9580093 12,19594067 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) PcomAs 7d 34,21791671 31,11728145 26,79864966 43,48793622 
BCCAS_2 ECAs, 2 prominent PcomAs 0d 148,1978054 119,5375315 101,7579657 101,3710414 
BCCAS_2 ECAs, 2 prominent PcomAs 1d 119,1587748 40,91341499 38,51441863 35,50790529 
BCCAS_2 ECAs, 2 prominent PcomAs 7d 49,31353771 74,0564812 43,84745201 61,81320127 
BCCAS_2 ECAs, 1 prominent (R) PcomA 0d 119,4653261 118,9142491 102,1385652 106,762177 
BCCAS_2 ECAs, 1 prominent (R) PcomA 1d 18,43742585 18,3667939 11,84601379 20,57022758 
BCCAS_2 ECAs, 1 prominent (R) PcomA 7d 27,15245614 25,93613271 27,23285421 25,98505416 
BCCAS_2 ECAs, 1 prominent (L), 1 small (R) PcomAs 0d 96,30399541 92,85534639 83,38072698 79,593287 
BCCAS_2 ECAs, 1 prominent (L), 1 small (R) PcomAs 1d 11,244445 16,76109829 24,81191087 20,32340446 
BCCAS_2 ECAs, 1 prominent (L), 1 small (R) PcomAs 7d 47,50977888 37,25285076 50,39292132 24,51169131 
BCCAS_2 ECAs, 1 prominent (R), 1 small (L) PcomAs 0d 105,3243051 102,2613978 95,99867676 86,93208341 
BCCAS_2 ECAs, 1 prominent (R), 1 small (L) PcomAs 1d 20,24317276 31,50885495 27,67283483 30,76080368 
BCCAS_2 ECAs, 1 prominent (R), 1 small (L) PcomAs 7d 29,725681 22,30161511 35,87385678 26,22280155 
BCCAS_1 ECA (R), 1 prominent (L) PcomA 0d 105,9159861 115,5616856 93,46209257 91,84569293 
BCCAS_1 ECA (R), 1 prominent (L) PcomA 1d 8,548924982 37,63401024 20,33453735 42,68682635 
BCCAS_1 ECA (R), 1 prominent (L) PcomA 7d 25,27066323 43,56697057 33,86099161 56,88317673 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 0d 150,948701 162,7002073 124,7177342 131,4578272 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 1d 26,57978798 6,420303985 36,03173341 22,8710745 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 7d 34,6706141 30,26654468 35,60939813 28,60813856 
BCCAS_1 ECA (L)_2 prominent PcomAs 0d 123,1388995 134,2918251 115,1781724 105,0895912 
BCCAS_1 ECA (L)_2 prominent PcomAs 1d 46,59561613 9,356240452 41,25656616 13,2522298 
BCCAS_1 ECA (L)_2 prominent PcomAs 7d 35,78513463 35,47261824 39,44967665 39,18432408 
BCCAS_2 ECAs, 1 prominent (R), 1 non-patent PcomA 0d 140,6842408 143,871155 119,5649627 121,8189768 
BCCAS_2 ECAs, 1 prominent (R), 1 non-patent PcomA 1d 50,50360711 57,07628213 59,10361578 52,15501891 
BCCAS_2 ECAs, 1 prominent (R), 1 non-patent PcomA 7d 23,14678341 11,00366503 28,86077124 14,74550895 
BCCAS_1 ECA (L)_2 very prominent PcomAs 0d 145,5783979 147,9625691 126,5684181 123,9633927 
BCCAS_1 ECA (L)_2 very prominent PcomAs 1d 33,2317219 16,784005 28,89517024 17,25487531 
BCCAS_1 ECA (L)_2 very prominent PcomAs 7d 27,62065712 29,50330075 31,64862085 54,76417538 
BCCAS_1 ECA (L),no PcomAs 0d 168,0959761 170,1882061 138,9689797 135,6249711 
BCCAS_1 ECA (L),no PcomAs 1d 20,41111115 8,628693719 33,39621499 13,58930286 
BCCAS_1 ECA (L),no PcomAs 7d 0 0 0 0 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 0d 110,9645619 111,4418065 117,0161945 117,1090963 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 1d 19,4037094 11,31069992 29,95191682 20,84810936 
BCCAS_1 ECA (L), 1 prominent PcomA (R) 7d 23,05738228 21,0720244 23,63616542 39,14571221 
BCCAS_2 ECAs, 1 prominent (R) PcomA 0d 151,1678728 156,5888276 131,3001053 126,8715154 
BCCAS_2 ECAs, 1 prominent (R) PcomA 1d 24,39315253 12,89354549 26,27374452 13,66020014 
BCCAS_2 ECAs, 1 prominent (R) PcomA 7d 41,21464798 48,53516517 37,56716301 42,34493351 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) PcomAs 0d 142,9266555 142,1960638 119,6681323 117,5792076 
BCCAS_1 ECA (L), 1 prominent (R), 1 small (L) PcomAs 1d 40,99092955 10,59265714 44,66482211 22,73320437 
















BCCAS_1 ECA (L), 2 non-
patent PcomAs d0-d1 86,51 93,21 73,22 82,26 
BCCAS_03 d0-d1 93,44 99,12 76,8 91,73 
BCCAS_2 ECAs_1 
prominent PcomA (R) d0-d1 51,34 81,69 50,84 73,65 
BCCAS_1 ECA (L), 1 
prominent (R), 1 small (L) 
PcomAs d0-d1 61,32 82,36 56,097 85,51 
BCCAS_2 ECAs, 2 
prominent PcomAs d0-d1 19,56 65,77 62,14 64,96 
BCCAS_10 d0-d1 97,09 98,59 83,81 94,57 
BCCAS_2 ECAs, 1 
prominent (R) PcomA d0-d1 84,54 84,54 88,51 80,73 
BCCAS_2 ECAs, 1 
prominent (L), 1 small (R) 
PcomAs d0-d1 88,26 81,84 70,23% 74,45 
BCCAS_2 ECAs, 1 
prominent (R), 1 small (L) 
PcomAs d0-d1 80,77 69,18 71,16 64,61 
BCCAS_1 ECA (R), 1 
prominent (L) PcomA d0-d1 91,92 67,4 78,23 53,51 
BCCAS_20 d0-d1 98,02 83,61 88,87 73,3 
BCCAS_1 ECA (L), 1 
prominent PcomA (R) d0-d1 82,38 96,04 71,1 82,12 
BCCAS_1 ECA (L)_2 
prominent PcomAs d0-d1 62,15 93,02 64,17 87,38 
BCCAS_2 ECAs, 1 
prominent (R), 1 non-
patent PcomA d0-d1 64,1 60,32 50,56 57,18 
BCCAS_1 ECA (L)_2 very 
prominent PcomAs d0-d1 77,16 88,65 77,16 86,07 
BCCAS_1 ECA (L),no 
PcomAs d0-d1 87,85 94,92 75,96 89,95 
BCCAS_1 ECA (L), 1 
prominent PcomA (R) d0-d1 82,51 90,2 87,06 82,19 
BCCAS_2 ECAs, 1 
prominent (R) PcomA d0-d1 83,86 91,76 79,96 89 
BCCAS_1 ECA (L), 1 
prominent (R), 1 small (L) 
PcomAs d0-d1 71,31 92,54 62,67 80,66 
BCCAS_1 ECA (L), 2 non-
patent PcomAs d0-d7 86,46 81,7 79 70,72 
BCCAS_03 d0-d7 NA NA NA NA 
BCCAS_2 ECAs_1 
prominent PcomA (R) d0-d7 52,74 71,83 59 60 
BCCAS_1 ECA (L), 1 
prominent (R), 1 small (L) 
PcomAs d0-d7 65,98 67,13 68,17 47,55 
BCCAS_2 ECAs, 2 
prominent PcomAs d0-d7 66,72 38 56,9 39 
BCCAS_10 d0-d7 NA NA NA NA 
BCCAS_2 ECAs, 1 
prominent (R) PcomA d0-d7 77,27 78,79 73,33 75,47 
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BCCAS_2 ECAs, 1 
prominent (L), 1 small (R) 
PcomAs d0-d7 50,67 59,8 39,5 69,18 
BCCAS_2 ECAs, 1 
prominent (R), 1 small (L) 
PcomAs d0-d7 71,78 78,39 62,63 69,8 
BCCAS_1 ECA (R), 1 
prominent (L) PcomA d0-d7 75,5 62,6 63,46 38 
BCCAS_20 d0-d7 NA NA NA NA 
BCCAS_1 ECA (L), 1 
prominent PcomA (R) d0-d7 77 81,48 71,4 78,2 
BCCAS_1 ECA (L)_2 
prominent PcomAs d0-d7 70,9 73,74 65,75 62,7 
BCCAS_2 ECAs, 1 
prominent (R), 1 non-
patent PcomA d0-d7 83,5 92,3 75,27 87,8 
BCCAS_1 ECA (L)_2 very 
prominent PcomAs d0-d7 80,6 80,27 74,27 55,7 
BCCAS_1 ECA (L),no 
PcomAs d0-d7 NA NA NA NA 
BCCAS_1 ECA (L), 1 
prominent PcomA (R) d0-d7 78,7 81 79,8 66,63 
BCCAS_2 ECAs, 1 
prominent (R) PcomA d0-d7 72,7 68,97 71,4 66,66 
BCCAS_1 ECA (L), 1 
prominent (R), 1 small (L) 
PcomAs d0-d7 41,28 52,4 39,5 52,62 
 
Table S4 
Brain region Time Percentage affected 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 12 
Cerebral cortex_L 0-1d 1 
Cerebral cortex_L 0-1d 33 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_L 0-1d 0 
Cerebral cortex_R 0-1d 7 
Cerebral cortex_R 0-1d 5 
Cerebral cortex_R 0-1d 34 
Cerebral cortex_R 0-1d 3 
Cerebral cortex_R 0-1d 5 
Cerebral cortex_R 0-1d 30 
Cerebral cortex_R 0-1d 0 
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Cerebral cortex_R 0-1d 60 
Cerebral cortex_R 0-1d 13 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 5 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 13 
Cerebral cortex_R 0-1d 13 
Cerebral cortex_R 0-1d 6 
Cerebral cortex_R 0-1d 0 
Cerebral cortex_R 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 26 
Striatum_L 0-1d 35 
Striatum_L 0-1d 25 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_L 0-1d 0 
Striatum_R 0-1d 7 
Striatum_R 0-1d 16 
Striatum_R 0-1d 34 
Striatum_R 0-1d 22 
Striatum_R 0-1d 20 
Striatum_R 0-1d 17 
Striatum_R 0-1d 0 
Striatum_R 0-1d 61 
Striatum_R 0-1d 20 
Striatum_R 0-1d 0 
Striatum_R 0-1d 0 
Striatum_R 0-1d 0 
Striatum_R 0-1d 3 
Striatum_R 0-1d 0 
Striatum_R 0-1d 0 
Striatum_R 0-1d 21 
Striatum_R 0-1d 10 
Striatum_R 0-1d 21 
Striatum_R 0-1d 0 
Striatum_R 0-1d 5 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
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corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 12 
corpus callosum_L 0-1d 8 
corpus callosum_L 0-1d 45 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_L 0-1d 0 
corpus callosum_R 0-1d 21 
corpus callosum_R 0-1d 18 
corpus callosum_R 0-1d 50 
corpus callosum_R 0-1d 21 
corpus callosum_R 0-1d 10 
corpus callosum_R 0-1d 30 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 58 
corpus callosum_R 0-1d 18 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 8 
corpus callosum_R 0-1d 29 
corpus callosum_R 0-1d 14 
corpus callosum_R 0-1d 0 
corpus callosum_R 0-1d 2 
 
Table S5 
Mouse.ID_Left PcomA size Time CBF.L.Cx CBF.R.Cx CBF_L_S CBF_R_S 
MCAO_small PcomA 0d 121,7217438 134,8766681 122,9761684 117,1312997 
MCAO_small PcomA 1d 28,11460357 86,02938802 23,57986906 77,77926985 
MCAO_small PcomA w1 54,38543794 22,95552849 72,17551682 27,34018097 
MCAO_small PcomA w4 157,2796521 147,0541602 126,2804012 129,9610161 
MCAO_small PcomA w7 133,6648216 130,8575839 121,8730259 120,0237001 
MCAO_prominent PcomA 0d 91,89100813 87,54875419 80,36110607 83,92087564 
MCAO_prominent PcomA 1d 71,67986638 151,7484785 36,88779875 121,7840909 
MCAO_prominent PcomA w1 113,6189911 170,3991775 0 133,728953 
MCAO_prominent PcomA w4 132,0771617 154,3481298 107,3513106 128,0006119 
MCAO_prominent PcomA w7 119,1819764 140,2194457 112,1499883 118,7902366 
MCAO_prominent PcomA 0d 79,64408888 154,1177827 83,58249192 132,8262835 
MCAO_prominent PcomA 1d 35,13595138 89,88345149 31,82496254 88,36865303 
MCAO_prominent PcomA w1 105,4804127 142,2192799 83,0250103 118,3368802 
MCAO_prominent PcomA w4 90,6257627 89,17967317 79,01271079 100,7622792 
MCAO_prominent PcomA w7 146,3542814 146,6366963 111,2093674 133,7403165 
MCAO_prominent PcomA 0d 119,1587748 119,5375315 101,7579657 101,3710414 
MCAO_prominent PcomA 1d 70,18400005 132,0139974 48,87765355 125,8893253 
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MCAO_prominent PcomA w1 119,2303177 166,2346609 87,24550809 128,9586508 
MCAO_prominent PcomA w4 117,8818366 136,9686466 112,9045791 118,2937734 
MCAO_prominent PcomA w7 99,36974484 128,936467 99,05773658 114,4640201 
Sham1 0d 119,4653261 118,9142491 102,1385652 106,762177 
Sham1 1d 95,40773809 165,3733118 86,77067779 135,8055664 
Sham1 w1 68,80468015 127,1829102 66,21255324 105,1416849 
Sham1 w4 87,30362146 132,6185576 56,38629951 107,9326888 
Sham1 w7 101,4382349 141,9378982 74,21481655 113,229796 
MCAO_small PcomA 0d 109,1558396 105,6512367 92,69781618 79,96049683 
MCAO_small PcomA 1d 0 0 0 0 
MCAO_small PcomA w1 119,6398383 183,7070966 103,0997559 145,4374715 
MCAO_small PcomA w4 143,4835418 170,123128 137,9077555 129,6729223 
MCAO_small PcomA w7 130,329132 153,0085083 113,0766475 120,935117 
MCAO_prominent PcomA 0d 135,3999529 143,6141366 113,3120275 110,6217667 
MCAO_prominent PcomA 1d 49,80093722 117,8356514 32,40303897 93,83683181 
MCAO_prominent PcomA w1 104,1966553 154,2536126 84,35959741 138,8184953 
MCAO_prominent PcomA w4 120,2369094 154,9890631 133,4563288 117,1103254 
MCAO_prominent PcomA w7 123,5163482 149,0102428 122,7696109 124,2652151 
MCAO_prominent PcomA 0d 141,0751801 151,2674909 117,1686339 126,3095457 
MCAO_prominent PcomA 1d 62,60551936 112,8711947 58,36682414 118,2665262 
MCAO_prominent PcomA w1 89,4910837 144,667316 65,98567942 120,8872173 
MCAO_prominent PcomA w4 125,3777166 155,5320208 96,87818551 134,110661 
MCAO_prominent PcomA w7 119,3147637 136,091236 90,15111209 124,05892 
MCAO_prominent PcomA 0d 159,6188021 163,0713475 125,4221499 126,1275405 
MCAO_prominent PcomA 1d 72,04860286 115,5982871 57,68180814 121,0446762 
MCAO_prominent PcomA w1 113,4569191 157,3518266 101,4835062 127,4698746 
MCAO_prominent PcomA w4 131,5005995 148,5281889 104,4503006 118,6542149 
MCAO_prominent PcomA w7 164,4916357 172,5210105 129,6684647 138,3786645 
MCAO_very prominent PcomA 0d 136,9510057 142,846421 115,5675102 116,8556913 
MCAO_very prominent PcomA 1d 71,58856537 130,0644248 67,74080225 110,9469922 
MCAO_very prominent PcomA w1 90,94006188 125,0471314 79,2300916 113,3440965 
MCAO_very prominent PcomA w4 93,48691981 130,5689666 89,04324161 109,774079 
MCAO_very prominent PcomA w7 0 0 0 0 
MCAO_small PcomA 0d 167,463899 172,3423476 132,3825998 135,6736347 
MCAO_small PcomA 1d 35,34085609 106,9577445 25,18028777 101,3700067 
MCAO_small PcomA w1 125,6495675 179,6539852 81,0460181 138,0671222 
MCAO_small PcomA w4 179,2040424 206,1029775 182,4631331 161,030311 





size Time %CBF_reduction_Cx_L %CBF_reduction_Cx_R %CBF_reduction_S_L %CBF_reduction_S_R 
MCAO_small PcomA d0-d1 76,89 36,21 80,82 33,59 
MCAO_small PcomA d0-d1 78,89 37,93 80,97 25,28 
MCAO_prominent 
PcomA d0-d1 21,99 NA 54,09 NA 
MCAO_prominent 
PcomA d0-d1 55,87 41,67 61,91 33,46 
MCAO_prominent 
PcomA d0-d1 41,09 NA 51,96 NA 
MCAO_prominent 




PcomA d0-d1 55,61 25,37 50,18 6,36 
MCAO_prominent 
PcomA d0-d1 54,86 29,1 54 4 
MCAO_very 











MCAO_very prominent PcomA day 1 13,39714495 5% 
MCAO_prominent PcomA day 1 20,02939958 8% 
MCAO_prominent PcomA day 1 23,08122521 9% 
MCAO_prominent PcomA day 1 24,89129654 9% 
MCAO_prominent PcomA day 1 28,77980789 11% 
MCAO_prominent PcomA day 1 29,23733173 11% 
MCAO_prominent PcomA day 1 38,43306202 15% 
MCAO_small PcomA day 1 65,39954876 25% 
MCAO_small PcomA day 1 78,11740365 29% 
MCAO_small PcomA day 1 85,14236361 32% 
MCAO_small PcomA day 1 89,2053737 34% 
MCAO_very prominent PcomA day 7 2,230229627 1% 
MCAO_prominent PcomA day 7 3,343831967 1% 
MCAO_prominent PcomA day 7 11,71405527 4% 
MCAO_prominent PcomA day 7 13,701572 5% 
MCAO_prominent PcomA day 7 13,85040924 5% 
MCAO_prominent PcomA day 7 15,83031419 6% 
MCAO_prominent PcomA day 7 22,3526425 8% 
MCAO_small PcomA day 7 42,40507117 16% 
MCAO_small PcomA day 7 68,47733648 26% 





Left PcomA size 
Brain region Left 
Hemisphere Percentage affected 
1_small Cortex 50 
1_small Striatum 70 
1_small Hippocampus 80 
1_small Orbital cortex 2 
1_small Cerebellum 0,001 
2_prominent Cortex 22 
2_prominent Striatum 48 
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2_prominent Hippocampus 7 
2_prominent Cortex 14 
2_prominent Striatum 54 
2_prominent Hippocampus 4 
2_prominent Orbital cortex 1 
2_prominent Cortex 12 
2_prominent Striatum 30 
2_prominent Hippocampus 1 
2_prominent Cortex 14 
2_prominent Striatum 53 
2_prominent Hippocampus 1 
3_very prominent Cortex 7 
3_very prominent Striatum 24 
1_small Cortex 42 
1_small Striatum 67 
1_small Hippocampus 76 
1_small Cerebellum 0,2 
2_prominent Cortex 12 
2_prominent Striatum 38 
2_prominent Hippocampus 1 
2_prominent Cortex 12 
2_prominent Striatum 54 
1_small Cortex 60 
1_small Striatum 60 
1_small Hippocampus 95 
1_small Orbital cortex 9 
1_small Cerebellum 0,13 
1_small Cortex 38 
1_small Striatum 77 
1_small Hippocampus 72 
1_small Orbital cortex 2 
 
Table S9 
Mouse.ID Striatal largest arteriole diameter (mm) 
NAIVE 0.03651 0.02573 0.01574           
BCCAS_infarct area 0.02830 0.02655 0.02053 0.01749 0.01796       
BCCAS_infarct area 0.05344 0.02398 0.02865 0.02452         
















naïve cortex_Left 538,3704897 0,049847623 1088 
naïve cortex_Right 408,6903821 0,039334495 1175 
naïve striatum_Left 355,6721503 0,036566375 1164 
naïve striatum_Right 391,0079025 0,042796819 1104 
BCCAS_1 cortex_Left 522,4351129 0,055807835 1002 
BCCAS_1 cortex_Right 616,5044471 0,058832959 1057 
BCCAS_1 striatum_Left 692,9458399 0,093067768 791 
BCCAS_1 striatum_Right 634,7130674 0,064552666 994 
BCCAS_2 cortex_Left 548,863401 0,071661121 884 
BCCAS_2 cortex_Right 658,5747613 0,063180476 1044 
BCCAS_2 striatum_Left 548,2891093 0,071187674 895 
BCCAS_2 striatum_Right 616,0381077 0,076430543 875 
BCCAS_4 cortex_Left 360,6388728 0,046694139 970 
BCCAS_4 cortex_Right 394,7299786 0,040909783 1120 
BCCAS_4 striatum_Left 348,4005167 0,061089738 806 
BCCAS_4 striatum_Right 303,898082 0,058197479 785 
MCAO_1 cortex_Left 658,9182335 0,070574473 973 
MCAO_1 cortex_Right 562,9044029 0,062687072 1009 
MCAO_1 striatum_Left 623,4726576 0,092521882 768 
MCAO_1 striatum_Right 564,6675492 0,090903854 746 
MCAO_2 cortex_Left NA NA 671 
MCAO_2 cortex_Right 233,9091131 0,041284494 737 
MCAO_2 striatum_Left 472,3904296 0,060927978 904 
MCAO_2 striatum_Right 552,3762872 0,061035782 970 
MCAO_3 cortex_Left 676,8706775 0,067844597 1022 
MCAO_3 cortex_Right 454,6780947 0,057019713 936 
MCAO_3 striatum_Left 774,2579954 0,084993157 936 










MCAO_1_left_Leptomeningeal v 37,84502066 99 95,68626827 
MCAO_1_right_Leptomeningeal v 36,46495324 85 83,08071571 
MCAO_2_left_Leptomeningeal v 37,12607738 84 87,46316817 
MCAO_2_right_Leptomeningeal v 36,01516261 94 65,77021257 
MCAO_4_left_Leptomeningeal v 37,59026701 86 109,7156665 
MCAO_4_right_Leptomeningeal v 38,70093985 91 104,8101798 
MCAO_6_left_Leptomeningeal v 41,43978119 176 163,7828147 
MCAO_6_right_Leptomeningeal v 41,78779508 149 143,361486 
MCAO_7_left_Leptomeningeal v 46,50272828 375 186,7528486 
MCAO_7_right_Leptomeningeal v 48,09327241 407 356,4544359 
MCAO_8_left_Leptomeningeal v 38,5719458 108 81,1014878 
MCAO_8_right_Leptomeningeal v 39,13602043 113 88,76021837 
MCAO_9_left_Leptomeningeal v 48,45307609 356 231,9044094 
MCAO_9_right_Leptomeningeal v 49,57505422 340 236,5029897 
MCAO_10_left_Leptomeningeal v 44,53095558 343 153,6039238 
MCAO_10_right_Leptomeningeal v 46,23538239 393 149,4258428 
MCAO_11_left_Leptomeningeal v 52,98720405 766 348,4308786 
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MCAO_11_right_Leptomeningeal v 51,880023 721 380,5143175 
MCAO_12_left_Leptomeningeal v 48,25368554 571 170,4217349 
MCAO_12_right_Leptomeningeal v 51,34258546 646 276,4347156 
MCAO_13_left_Leptomeningeal v 51,13976663 732 258,1223597 
MCAO_13_right_Leptomeningeal v 44,77579624 708 229,3120222 
MCAO_14_left_Leptomeningeal v 43,12752506 412 257,1447909 
MCAO_14_right_Leptomeningeal v 55,61812973 751 974,3970818 
MCAO_16_left_Leptomeningeal v 46,73768654 435 190,1541202 
MCAO_16_right_Leptomeningeal v 48,75711723 488 247,2762852 
MCAO_17_left_Leptomeningeal v 48,58739808 497 247,7346537 
MCAO_17_right_Leptomeningeal v 47,31696907 434 165,9395078 
NAIVE_16_left_Leptomeningeal v 39,75546113 109 128,7679384 
NAIVE_16_right_Leptomeningeal v 39,80904229 79 101,5077038 
NAIVE_17_left_Leptomeningeal v 42,167035 123 112,1555254 
NAIVE_17_right_Leptomeningeal v 40,39368916 115 97,21504817 
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